EcoDrugPlus

Ensembl ID : ENSLACG00000014843
Gene Symbol: RPL13
1 Cross references
269 Possible Orthologues:

Ensembl ID : ENSLACG00000002299
Gene Symbol: RPL13
1 Cross references
269 Possible Orthologues:

Ensembl ID : ENSLACG00000005788
Gene Symbol: RPL8
1 Cross references
232 Possible Orthologues:

Ensembl ID : ENSLACG00000003010
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSLACG00000014416
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSLACG00000004220
Gene Symbol: -
Cross references: -
132 Possible Orthologues:

Ensembl ID : ENSLACG00000018001
Gene Symbol: -
Cross references: -
240 Possible Orthologues:

Ensembl ID : ENSLACG00000015438
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSLACG00000001622
Gene Symbol: -
Cross references: -
586 Possible Orthologues:

Ensembl ID : ENSLACG00000013660
Gene Symbol: -
Cross references: -
236 Possible Orthologues:

Ensembl ID : ENSLACG00000010434
Gene Symbol: -
Cross references: -
287 Possible Orthologues:

Ensembl ID : ENSLACG00000000747
Gene Symbol: RPL10A
1 Cross references
84 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).